Short answer
HERON THERAPEUTICS, INC. /DE/ (HRTX) filed an 8-K current report with the SEC on June 2, 2026 reporting Item 8.01 (Other Events). Delaware court held asserted CINVANTI patents 12,115,255 and 12,290,520 invalid on June 1, 2026.
HERON THERAPEUTICS, INC. /DE/ 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Delaware court held asserted CINVANTI patents 12,115,255 and 12,290,520 invalid on June 1, 2026
- Heron intends Federal Circuit appeal, preserving potential patent protection against Azurity’s generic CINVANTI
- Decision has no impact on prior CINVANTI or APONVIE settlement agreements
- Appeal outcome and any stay of market entry remain material risks to CINVANTI revenue protection
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other HERON THERAPEUTICS, INC. /DE/ 8-K filings
Get the next HRTX 8-K as it lands
Follow HRTX for push alerts, or ask the research agent what this filing means.